Regulatory Perspectives on AI Use in Maintenance and Process Monitoring The use of Artificial Intelligence (AI) and Machine Learning (ML) in the pharmaceutical industry, particularly within Good Manufacturing Practice (GMP) plants, has gained significant traction in recent years. As organizations increasingly adopt these technologies in maintenance and process monitoring settings, it becomes essential to understand the regulatory landscape that governs their implementation. This article provides a step-by-step tutorial detailing the FDA expectations surrounding AI predictive maintenance, Continued Process Verification (CPV) dashboards, and the use of advanced analytics in GMP environments. 1. Understanding the Regulatory Framework for AI in Pharma The…

Building Cross-Functional Teams for CPV Analytics and Predictive Maintenance In the pharmaceutical and biotechnology sectors, the need for effective monitoring and maintenance systems is increasingly crucial. With the integration of advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) into this field, stakeholders can optimize their processes significantly. In this regulatory tutorial, we provide a comprehensive step-by-step guide for building cross-functional teams focused on continued process verification (CPV) analytics and AI predictive maintenance within Good Manufacturing Practice (GMP) environments. Understanding FDA Expectations for AI in GMP Plants The U.S. Food and Drug Administration (FDA) has established regulatory paradigms…

Backup, Redundancy and Disaster Recovery for GxP Control Systems Backup, Redundancy and Disaster Recovery for GxP Control Systems Introduction to Data Historian Validation and Automation Systems In FDA-regulated environments, especially within the pharmaceutical sector, maintaining the integrity of data is paramount. Data historians, SCADA (Supervisory Control and Data Acquisition) systems, DCS (Distributed Control Systems), and PLC (Programmable Logic Controllers) play crucial roles in GMP (Good Manufacturing Practices) process control. Ensuring proper backup, redundancy, and disaster recovery for these GxP (Good Practice) control systems is not merely a technical requirement but also a regulatory obligation. This tutorial aims to guide pharma…

Risk-Based Testing Strategies for Complex DCS and PLC Architectures Risk-Based Testing Strategies for Complex DCS and PLC Architectures Advancements in technology have led to increasingly complex and integrated systems within manufacturing environments, especially in the pharmaceutical industry. These systems include Distributed Control Systems (DCS), Supervisory Control and Data Acquisition (SCADA) systems, and Programmable Logic Controllers (PLC). Ensuring that these complex architectures are compliant with regulations such as 21 CFR Part 11 is crucial for maintaining quality and data integrity in Good Manufacturing Practice (GMP) environments. This guide outlines a step-by-step approach for risk-based testing strategies that are essential for validating…

SCADA and DCS Validation Requirements in GMP Biotech and Pharma Plants SCADA and DCS Validation Requirements in GMP Biotech and Pharma Plants The validation of SCADA (Supervisory Control and Data Acquisition) and DCS (Distributed Control Systems) in GMP (Good Manufacturing Practice) biotech and pharma plants is vital for ensuring compliance with FDA regulations. As automation systems gain prominence in the pharmaceutical industry, understanding the associated regulatory requirements becomes increasingly crucial for professionals engaged in clinical operations, regulatory affairs, and medical affairs. Understanding the Basics of SCADA and DCS in GMP Environments SCADA and DCS are integral components of process control…

Validating Data Historians in FDA-Regulated Process Manufacturing Data historians are essential components in modern manufacturing environments, especially within the pharmaceutical, biotech, and medical device sectors. The validation of data historians in FDA-regulated processes ensures compliance with regulatory standards, such as 21 CFR Part 11, and supports the overall integrity of process control systems (SCADA, DCS, PLC). This step-by-step tutorial will guide pharma professionals through the regulatory expectations for validating data historians, focusing on best practices in automation systems, data integrity, and quality management practices. Understanding the Role of Data Historians in Process Control A data historian is a specialized software…

Aligning QA, IT and Manufacturing on Roles in EBR/MES Validation Aligning QA, IT and Manufacturing on Roles in EBR/MES Validation The integration of Electronic Batch Records (EBR) and Manufacturing Execution Systems (MES) into GMP manufacturing processes is critical to ensuring compliance with FDA regulations, particularly 21 CFR Part 11. This article serves as a comprehensive step-by-step regulatory tutorial on the expectations and best practices for aligning Quality Assurance (QA), Information Technology (IT), and manufacturing teams during EBR/MES validation. This alignment is essential to maintain data integrity, ensure compliance, and facilitate a culture of continuous improvement in FDA-regulated environments. Understanding the…

End-to-End Electronic Batch Record Lifecycle Controls for FDA Readiness As the pharmaceutical industry continually advances towards digital transformation, the implementation and management of Electronic Batch Records (EBR) have become paramount in ensuring compliance with FDA regulations. This step-by-step tutorial guides professionals in the pharmaceutical and biotechnology fields on managing the entire lifecycle of EBRs, aligning with 21 CFR Part 11 requirements while ensuring Good Manufacturing Practice (GMP) compliance. Understanding Electronic Batch Records (EBR) and Their Importance Electronic Batch Records (EBR) are digital documentation systems that replace traditional paper-based records in the pharmaceutical manufacturing process. These systems are integral to the…

Implementing Review-by-Exception in EBR Without Compromising Compliance Implementing Review-by-Exception in EBR Without Compromising Compliance Electronic Batch Records (EBR) and Manufacturing Execution Systems (MES) are integral components in the modern landscape of Good Manufacturing Practice (GMP) manufacturing. Regulatory compliance is paramount, and the complexities of maintaining compliance, especially under 21 CFR Part 11, can be significant. One of the evolving methodologies that can enhance operational efficiency while ensuring compliance is the concept of Review-by-Exception (RbE). This tutorial outlines a step-by-step approach to implementing RbE in EBR systems while adhering to FDA regulations, ensuring that your organization remains compliant while benefitting from…

Change Control and Periodic Review for Validated Computerized Systems In the evolving landscape of the pharmaceutical and biotech industries, compliance with the ever-increasing regulatory standards is paramount. This tutorial serves as a comprehensive guide for professionals dealing with validated computerized systems, emphasizing both change control and periodic review processes as they relate to computerized system validation (CSV). Understanding these processes is crucial for ensuring that systems remain compliant with FDA regulations, such as 21 CFR Part 11, and effectively manage risk throughout the product lifecycle. Understanding Computerized System Validation (CSV) Computerized system validation refers to the process of establishing and…